photothermal ablation
Recently Published Documents


TOTAL DOCUMENTS

269
(FIVE YEARS 91)

H-INDEX

45
(FIVE YEARS 8)

2021 ◽  
Vol 138 ◽  
pp. 104881
Author(s):  
Jason KK. Cheong ◽  
Viktor Popov ◽  
Elisa Alchera ◽  
Irene Locatelli ◽  
Massimo Alfano ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Dmitry A. Nedosekin ◽  
TsungYen Chen ◽  
Srinivas Ayyadevara ◽  
Vladimir P. Zharov ◽  
Robert J. Shmookler Reis

AbstractAggregation of proteins is a prominent hallmark of virtually all neurodegenerative disorders including Alzheimer’s, Parkinson’s and Huntington’s diseases. Little progress has been made in their treatment to slow or prevent the formation of aggregates by post-translational modification and regulation of cellular responses to misfolded proteins. Here, we introduce a label-free, laser-based photothermal treatment of polyglutamine (polyQ) aggregates in a C. elegans nematode model of huntingtin-like polyQ aggregation. As a proof of principle, we demonstrated that nanosecond laser pulse-induced local photothermal heating can directly disrupt the aggregates so as to delay their accumulation, maintain motility, and extend the lifespan of treated nematodes. These beneficial effects were validated by confocal photothermal, fluorescence, and video imaging. The results obtained demonstrate that our theranostics platform, integrating photothermal therapy without drugs or other chemicals, combined with advanced imaging to monitor photothermal ablation of aggregates, initiates systemic recovery and thus validates the concept of aggregate-disruption treatments for neurodegenerative diseases in humans.


2021 ◽  
Author(s):  
Arezoo Shahrivarkevishahi ◽  
Michael A. Luzuriaga ◽  
Fabian C. Herbert ◽  
Alisia C. Tumac ◽  
Olivia R. Brohlin ◽  
...  

ABSTRACT: Virus-like particles (VLPs) are multifunctional nanocarriers that mimic the architecture of viruses. They can serve as a safe platform for specific functionalization and immunization, which provides benefits in a wide range of biomedical applications. In this work, a new generation immunophotothermal agent is developed that adjuvants photothermal ablation using a chemically modified VLP called bacteriophage Qβ. The design is based on the conjugation of near-infrared absorbing croconium dyes to lysine residues located on the surface of Qβ, which turns it to a powerful NIR-absorber called Photothermal Phage. This system can generate more heat upon 808 nm NIR laser radiation than free dye and possesses a photothermal efficiency comparable to gold nanostructures, yet it is biodegradable and acts as an immunoadjuvant combined with the heat it produces. The synergistic combination of thermal ablation with the mild immunogenicity of the VLP leads to effective suppression of primary tumors, reduced lung metastasis, and increased survival time.


Author(s):  
Amir Zarebkohan ◽  
Abbas Ghafoori ◽  
Farhad Bani ◽  
Seyed Hossein Rasta ◽  
Elham Abasi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document